Filter
567
Text search:
variants
Featured
Recommendations
85
New Publications
54
Language
Document type
Guidelines
140
Studies & Reports
127
No document type
127
Fact sheets
56
Strategic & Response Plan
37
Manuals
33
Videos
14
Situation Updates
10
Training Material
9
Resource Platforms
7
Infographics
4
Brochures
3
Countries / Regions
Global
35
Africa
23
Latin America and the Carribbean
17
India
15
Brazil
14
Western and Central Europe
11
Germany
10
Russia
10
Kenya
8
Syria
6
South Africa
6
Nigeria
5
Ethiopia
5
Niger
5
East and Southern Africa
5
West and Central Africa
5
Middle East and North Africa
5
Congo, Democratic Republic of
4
South Sudan
4
Malawi
4
Mozambique
4
Colombia
4
Eastern Europe
4
Senegal
3
Cameroon
3
Uganda
3
Haiti
3
Lebanon
3
Peru
3
Bolivia
3
Myanmar / Burma
3
Chile
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Asia
3
Venezuela
3
Spain
3
Burkina Faso
2
Liberia
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Ghana
2
Philippines
2
Turkey
2
Chad
2
Rwanda
2
Bangladesh
2
Sudan
2
Argentina
2
Ukraine
2
Nicaragua
2
Yemen
2
Kazakhstan
2
France
2
Tunisia
2
Guinea
1
Sierra Leone
1
Saudi Arabia
1
Zimbabwe
1
Somalia
1
Pakistan
1
Iraq
1
Jordan
1
Afghanistan
1
Egypt
1
Tanzania
1
China
1
Indonesia
1
Mauritania
1
Benin
1
Central African Republic
1
Dominican Republic
1
Eswatini/ Swaziland
1
North Macedonia
1
Serbia
1
Cuba
1
Honduras
1
Ecuador
1
El Salvador
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Western Pacific Region
1
Palestine
1
Armenia
1
Southern Africa
1
Congo-Brazzaville
1
Tajikistan
1
Qatar
1
Moldova
1
Uzbekistan
1
Kyrgyzstan
1
Georgia
1
Vietnam
1
Gabon
1
Jamaica
1
United Kingdom
1
Portugal
1
Belarus
1
French Guyana
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
147
Clinical Guidelines
43
Public Health
29
Key Resources
18
Pharmacy & Technologies
15
Women & Child Health
9
Capacity Building
5
Toolboxes
COVID-19
267
Mental Health
34
HIV
25
NTDs
21
Rapid Response
20
TB
16
Planetary Health
16
AMR
15
NCDs
11
Malaria
11
Global Health Education
9
Health Financing Toolbox
9
2.0 Rapid Response
9
Ebola & Marburg
7
Conflict
7
Caregiver
5
Refugee
4
Specific Hazards
4
Pharmacy
4
Cholera
3
Disability
2
Polio
2
Natural Hazards
2
Zika
1
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus
...
Every country has been affected by COVID-19, with nearly a quarter
of a billion cases and almost 5 million deaths reported globally as of
end of September 2021. Despite the stunning speed with which highly
effective and safe vaccines have been developed, new waves of disease
are still pushin
...
Over 18 months into the pandemic, WHO continues to conductglobal surveillance of COVID-19as part of activities on preparedness, readiness and response activities. The need for global surveillance of COVID-19 is greater than ever, asthe implementation of vaccination campaigns and the appearance of
...
Covid-19 Test to Treat Guidelines
recommended
n response to the outbreak, the Africa Centres for Disease Control and Prevention (Africa CDC) has been supporting African Union Member States in responding to the COVID-19 pandemic through a variety of interventions such as non-pharmaceutical interventions, quarantine, testing, isolation, contact t
...
The aim of this article is to identify the elements behind the country’s successful COVID-19 rollout as well as lessons and chal lenges derived from this process. The analysis is relevant to many countries today—as they keep searching for strategies to cope with the second year of the COVID-19 p
...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for
...
Orientations provisoires, 28 janvier 2021
Dans cette version mise à jour des orientations sur la sécurité biologique en laboratoire en rapport avec le SARS-CoV-2, le virus responsable de la maladie à coronavirus 2019 (COVID-19), les points suivants ont été ajoutés : aspects de
...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr
...
22 April 2022, This document provides updated interim recommendations on the use of masks by health workers providing care to patients with suspected or confirmed COVID-19. This update is prompted by new evidence around mask use and COVID-19 transmission, as well as the emergence of
...
In 2021 ACT-Accelerator will intensify its drive for equity and scale in the delivery of essential COVID-19 tools, while managing emerging viral risks. To address these major shifts and maintain momentum, ACT-Accelerator has defined four strategic priorities for 2021: Rapidly scale up the delivery o
...
Countries across the world are facing diverse epidemiological situations with varying response
capacities and access to life saving tools. The World Health Organization (WHO) recommends that national authorities continue to apply a risk-based approach when implementing measures related to COVID-19
...
Les pays du monde entier sont confrontés à des situations épidémiologiques diverses, et disposent de capacités de réaction différentes et d’un accès inégal aux outils permettant de sauver des vies. L’Organisation mondiale de la Santé (OMS) recommande aux autorités nationales de contin
...
Lorsqu’un virus circule largement dans une population et entraîne de nombreuses infections, la probabilité de mutation augmente. Plus un virus a de possibilités de se propager, plus il se réplique – et plus il est susceptible de muter. L’arrêt de la propagation du virus à la source res
...
Dengue is the fastest spreading, mosquito-borne viral infectious disease worldwide, with remarkable morbidity and mortality. In the past decades, profound contributions have been made towards understanding its epidemiology, including disease burden and distributions, risk factors, and control and pr
...
WHO’s Science in 5 Episode #63 - Omicron variant
recommended
What do we know about Omicron variant so far? WHO's Dr Maria Van Kerkhove updates on the transmissibility, severity, symptoms and ways to protect yourself in Science in 5.
If Omicron is less severe, why are people ending up in the hospital and dying from it? Is it true that everyone will eventually get Omicron? Why is it important to reduce transmission? WHO's Dr Maria Van Kerkhove explains in Science in 5.
Sequencing SARS-CoV-2 in the Americas
The COVID-19 Genomic Surveillance Regional Network was created in 2020 not only to strengthen the sequencing capacity in the participating laboratories, but also for them to establish a routine SARS-CoV-2 genomic sequencing, as a strategy to increase the amoun
...
